Slow Cold Season Trims Matrixx Q4 Sales, But Net Loss Down By $2.5 Million
This article was originally published in The Tan Sheet
Executive Summary
A slow-starting cold season contributed to an 18 percent dip in fourth-quarter sales of Matrixx Initiatives' Zicam cough/cold and flu relief products, company President and CEO Carl Johnson says